Activated factor XI and tissue factor in inflammatory bowel disease.
作者信息
Undas A, Owczarek D, Gissel M, Salapa K, Mann K G, Butenas S
出版信息
Inflamm Bowel Dis. 2010 Sep;16(9):1447-8. doi: 10.1002/ibd.21206.
Abstract
摘要
相似文献
1
Activated factor XI and tissue factor in inflammatory bowel disease.炎症性肠病中的活化因子XI和组织因子
Inflamm Bowel Dis. 2010 Sep;16(9):1447-8. doi: 10.1002/ibd.21206.
2
RDW can be a useful additional marker in diagnosing Crohn's disease and ulcerative colitis.
Dig Dis Sci. 2008 Oct;53(10):2828-9. doi: 10.1007/s10620-008-0345-4. Epub 2008 Jul 16.
3
Serum lysozyme in inflammatory bowel disease.炎症性肠病中的血清溶菌酶
Gastroenterology. 1976 Jun;70(6):1014-6.
4
[C-reactive protein usefulness in diagnosis and survey of Crohn's disease and ulcerative colitis (author's transl)].
Gastroenterol Clin Biol. 1979 Nov;3(11):789-94.
5
Indices of granulocyte activity in ulcerative colitis and Crohn's disease.溃疡性结肠炎和克罗恩病中粒细胞活性指标
Dan Med Bull. 1977 Apr;24(2):72-6.
6
Clinical consideration of the cytokines in inflammatory bowel disease.
Am J Gastroenterol. 1995 Mar;90(3):520-1.
7
[Value of platelet count as an activity index in chronic inflammatory intestinal diseases].
Med Clin (Barc). 1988 Oct 1;91(10):397.
8
Heat shock protein 47 can be a new target molecule for intestinal fibrosis related to inflammatory bowel disease.
Inflamm Bowel Dis. 2010 Dec;16(12):2004-6. doi: 10.1002/ibd.21243.
9
C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.C反应蛋白：炎症性肠病中炎症的预测因子和标志物。一项基于人群的前瞻性研究结果
Gut. 2008 Nov;57(11):1518-23. doi: 10.1136/gut.2007.146357. Epub 2008 Jun 19.
10
Cellular and humoral indices of disease activity in inflammatory bowel disease.炎症性肠病中疾病活动的细胞和体液指标。
Digestion. 1978;17(5):387-95. doi: 10.1159/000198141.
引用本文的文献
1
Thrombogenic potential of picomolar coagulation factor XIa is mediated by thrombin wave propagation.皮摩尔凝血因子 XIa 的促血栓形成潜能是由凝血酶波传播介导的。
Blood Adv. 2023 Jun 13;7(11):2622-2631. doi: 10.1182/bloodadvances.2022008743.
2
Endoscopic activity, tissue factor and Crohn's disease: findings in clinical remission patients.内镜活动度、组织因子与克罗恩病：临床缓解期患者的研究结果
Therap Adv Gastroenterol. 2020 Aug 3;13:1756284820939412. doi: 10.1177/1756284820939412. eCollection 2020.
3
Detecting factor XIa in immune globulin products: Commutability of international reference materials for traditional and global hemostasis assays.检测免疫球蛋白产品中的因子XIa：传统和全球止血检测国际参考物质的互换性
Res Pract Thromb Haemost. 2020 Dec 23;5(1):211-222. doi: 10.1002/rth2.12467. eCollection 2021 Jan.
4
Endogenous Procoagulant Activity in Trauma Patients and Its Relationship to Trauma Severity.创伤患者的内源性促凝血活性及其与创伤严重程度的关系。
TH Open. 2019 Jan 7;3(1):e10-e19. doi: 10.1055/s-0038-1677030. eCollection 2019 Jan.
5
Continuous thrombin generation in whole blood: New applications for assessing activators and inhibitors of coagulation.全血中凝血酶的持续生成：评估凝血激活剂和抑制剂的新应用。
Anal Biochem. 2018 Jun 15;551:19-25. doi: 10.1016/j.ab.2018.05.005. Epub 2018 May 7.
6
Analysis of factor XIa, factor IXa and tissue factor activity in burn patients.烧伤患者中因子Xla、因子IXa和组织因子活性的分析。
Burns. 2018 Mar;44(2):436-444. doi: 10.1016/j.burns.2017.08.003. Epub 2017 Oct 9.
7
Synergy Between Tissue Factor and Exogenous Factor XIa in Initiating Coagulation.组织因子与外源性因子XIa在启动凝血过程中的协同作用。
Arterioscler Thromb Vasc Biol. 2016 Dec;36(12):2334-2345. doi: 10.1161/ATVBAHA.116.308186. Epub 2016 Oct 27.
8
TACTIC: Trans-Agency Consortium for Trauma-Induced Coagulopathy.策略：创伤性凝血病跨机构联盟
J Thromb Haemost. 2015 Jun;13 Suppl 1(0 1):S63-71. doi: 10.1111/jth.12981.
9
The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood: comment.玉米胰蛋白酶抑制剂以及针对因子Ⅺa和因子Ⅻa的抑制性抗体对血浆和全血凝血的影响：评论
J Thromb Haemost. 2015 Mar;13(3):487-8. doi: 10.1111/jth.12812. Epub 2015 Jan 14.
10
Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability.炎症性肠病：流行病学、病理学和高凝状态的危险因素。
World J Gastroenterol. 2014 Jan 7;20(1):53-63. doi: 10.3748/wjg.v20.i1.53.
本文引用的文献
1
Risk of arterial thrombotic events in inflammatory bowel disease.炎症性肠病中动脉血栓形成事件的风险
Am J Gastroenterol. 2009 Jun;104(6):1445-51. doi: 10.1038/ajg.2009.81. Epub 2009 Apr 21.
2
Factor XIa and tissue factor activity in patients with coronary artery disease.冠心病患者中的凝血因子Ⅺa和组织因子活性。
Thromb Haemost. 2008 Jan;99(1):142-9. doi: 10.1160/TH07-08-0499.
3
Activations of coagulation and fibrinolysis secondary to bowel inflammation in patients with ulcerative colitis.溃疡性结肠炎患者肠道炎症继发的凝血和纤溶激活。
Intern Med. 2007;46(17):1323-9. doi: 10.2169/internalmedicine.46.0237. Epub 2007 Sep 3.
4
Factor XI in haemostasis and thrombosis: past, present and future.凝血与血栓形成中的因子XI：过去、现在与未来。
Thromb Haemost. 2007 Jul;98(1):84-9.
5
Inflammation and coagulation in inflammatory bowel disease: The clot thickens.炎症性肠病中的炎症与凝血：凝块不断增厚。
Am J Gastroenterol. 2007 Jan;102(1):174-86. doi: 10.1111/j.1572-0241.2006.00943.x. Epub 2006 Nov 13.
6
Venous thrombosis in inflammatory bowel disease.炎症性肠病中的静脉血栓形成
Eur J Gastroenterol Hepatol. 2005 Jul;17(7):697-700. doi: 10.1097/00042737-200507000-00001.
7
Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?炎症性肠病是血栓栓塞的独立且疾病特异性危险因素吗？
Gut. 2004 Apr;53(4):542-8. doi: 10.1136/gut.2003.025411.
Zotero 插件